MenoGeniX Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MenoGeniX Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11235
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MenoGeniX Inc (MenoGeniX) is a biopharmaceutical company that develops treatment for menopausal women and cancer patients. The company provides pipeline products portfolio such as MNGX-100, is under Phase 1b human clinical trial. Its therapeutic agents are developed for new indications such as menopause, and the menopause-like symptoms in menopausal women and also in certain breast and prostate cancer patients undergoing androgen ablation therapy. MenoGeniX also provides hormone therapy (HT) with estrogens, integrated with health risks including cardiovascular disease and breast cancer. The company’s products are used as treatment to HT for women undergoing the menopause transition. MenoGeniX is headquartered in Aurora, Colorado, the US.

MenoGeniX Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MenoGeniX Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MenoGeniX Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MenoGeniX Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MenoGeniX Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MenoGeniX Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MenoGeniX Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
MenoGeniX Raises Funds Through Venture Financing 10
MenoGeniX Raises USD0.2 Million in Venture Financing 11
MenoGeniX Raises USD0.4 Million in Venture Financing 12
MenoGeniX Raises USD0.5 Million in Venture Financing 13
MenoGeniX Inc – Key Competitors 14
MenoGeniX Inc – Key Employees 15
MenoGeniX Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product News 17
05/03/2018: MenoGeniX Awarded NIH Grant to Fund Phase Ib/IIa Clinical Trial 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
MenoGeniX Inc, Pharmaceuticals & Healthcare, Key Facts 2
MenoGeniX Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MenoGeniX Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MenoGeniX Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MenoGeniX Inc, Deals By Therapy Area, 2012 to YTD 2018 8
MenoGeniX Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MenoGeniX Raises Funds Through Venture Financing 10
MenoGeniX Raises USD0.2 Million in Venture Financing 11
MenoGeniX Raises USD0.4 Million in Venture Financing 12
MenoGeniX Raises USD0.5 Million in Venture Financing 13
MenoGeniX Inc, Key Competitors 14
MenoGeniX Inc, Key Employees 15

List of Figures
MenoGeniX Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MenoGeniX Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MenoGeniX Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MenoGeniX Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MenoGeniX Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MenoGeniX Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MenoGeniX Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MenoGeniX Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[MenoGeniX Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kratos Defense & Security Solutions, Inc.:企業のM&A・事業提携・投資動向
    Kratos Defense & Security Solutions, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kratos Defense & Security Solutions, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Leaf Clean Energy Company (LEAF):企業の財務・戦略的SWOT分析
    Summary Leaf Clean Energy Company (Leaf Clean Energy) is a provider of renewable energy and sustainable technology investments. It offers growth and venture capital across the renewable energy industry to support novelty, well-managed and rapidly-growing companies. It operates and manages energy pro …
  • Regional Express Holdings Limited:企業の戦略・SWOT・財務情報
    Regional Express Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Regional Express Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Raymond Ltd (RAYMOND EQ):企業の財務・戦略的SWOT分析
    Raymond Ltd (RAYMOND EQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Revolution Lighting Technologies Inc (RVLT):企業の財務・戦略的SWOT分析
    Revolution Lighting Technologies Inc (RVLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Solvay Specialty Polymers Italy SpA:企業の戦略的SWOT分析
    Solvay Specialty Polymers Italy SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • A.H.A International Co., Ltd.:戦略・SWOT・企業財務分析
    A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Orbus Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Orbus Therapeutics Inc (Orbus Therapeutics) is a clinical-stage biopharmaceutical company that develops and commercializes drugs for the treatment of anaplastic astrocytoma, a rare kind of cancer afflicting the central nervous system. Eflornithine, a cytostatic agent, indicated for the treat …
  • MYOS RENS Technology Inc (MYOS):企業の財務・戦略的SWOT分析
    Summary MYOS RENS Technology Inc (MYOS RENS), formerly MYOS Corp is a bionutrition and biotherapeutics company that discovers, develops and commercializes products that improve muscle health and function. The company offers fortetropin, a unique bioactive composition derived from fertilized chicken …
  • Porcelanosa Grupo AIE:企業の戦略・SWOT・財務情報
    Porcelanosa Grupo AIE - Strategy, SWOT and Corporate Finance Report Summary Porcelanosa Grupo AIE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Power Corporation of Canada:企業の戦略・SWOT・財務分析
    Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report Summary Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • CAT Telecom Public Co Ltd:企業の戦略的SWOT分析
    CAT Telecom Public Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Keio Corporation (9008):企業の財務・戦略的SWOT分析
    Keio Corporation (9008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • ABB, Ltd.:企業の戦略・SWOT・財務情報
    ABB, Ltd. - Strategy, SWOT and Corporate Finance Report Summary ABB, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • bioMerieux SA (BIM)-医療機器分野:企業M&A・提携分析
    Summary bioMerieux S.A. (bioMerieux) designs, develops and manufactures diagnostic systems and reagents for physicians and biologists. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used diagnosing and managing infectious diseases, cardiov …
  • Natus Medical Incorporated (BABY):企業の財務・戦略的SWOT分析
    Natus Medical Incorporated (BABY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Kimball International, Inc. (KBAL):企業の財務・戦略的SWOT分析
    Kimball International, Inc. (KBAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Black Hills Power Inc:電力:M&Aディール及び事業提携情報
    Summary Black Hills Power Inc (Black Hills), a subsidiary of Black Hills Corp, is a power company that generates, transmits and distributes electricity. The company generates electricity through coal, gas, and oil resources. Its services include electricity and natural gas transmission and distribut …
  • Porton Fine Chemicals Ltd (300363):製薬・医療:M&Aディール及び事業提携情報
    Summary Porton Fine Chemicals Ltd (Porton) is a supplier of custom drug intermediates and active pharmaceutical ingredients. The company provides custom and contract chemical development, and contract manufacturing services. It provides products such as reactive reagents, chiral chromatography produ …
  • SPAGO Nanomedical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Spago Nanomedical AB (Spago Nanomedical), formerly Spago Imaging AB is a research and development company that develops nanomedical products for the diagnosis and treatment of cancer. The company offers spagopix, a magnetic resonance imaging contrast agent to improve the visualization of sof …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆